19/120
0.8 / 5 stars
All 120 Win/Lose results shown below
RCKT Roast Me summary
ROCKET PHARMACEUTICALS, INC. (RCKT). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseRCKT / S&P -4.47% / 15.20% |
LoseRCKT / S&P RCKT unavailable / 15.00% |
LoseRCKT / S&P RCKT unavailable / 50.40% |
| 2026-Q11/3 |
WinRCKT / S&P 1.99% / -4.33% |
LoseRCKT / S&P RCKT unavailable / 11.30% |
LoseRCKT / S&P RCKT unavailable / 27.70% |
| 2025-Q41/3 |
WinRCKT / S&P 7.67% / 2.65% |
LoseRCKT / S&P RCKT unavailable / 9.00% |
LoseRCKT / S&P RCKT unavailable / 13.40% |
| 2025-Q31/3 |
WinRCKT / S&P 33.06% / 8.12% |
LoseRCKT / S&P RCKT unavailable / 4.61% |
LoseRCKT / S&P RCKT unavailable / 13.45% |
| 2025-Q20/3 |
LoseRCKT / S&P -63.27% / 10.94% |
LoseRCKT / S&P RCKT unavailable / 4.83% |
LoseRCKT / S&P RCKT unavailable / 10.63% |
| 2025-Q10/3 |
LoseRCKT / S&P -46.94% / -4.27% |
LoseRCKT / S&P RCKT unavailable / 4.98% |
LoseRCKT / S&P RCKT unavailable / 10.57% |
| 2024-Q40/3 |
LoseRCKT / S&P -31.94% / 2.41% |
LoseRCKT / S&P RCKT unavailable / 5.25% |
LoseRCKT / S&P RCKT unavailable / 6.15% |
| 2024-Q30/3 |
LoseRCKT / S&P -14.21% / 5.89% |
LoseRCKT / S&P RCKT unavailable / 5.89% |
LoseRCKT / S&P RCKT unavailable / 6.11% |
| 2024-Q20/3 |
LoseRCKT / S&P -20.08% / 4.28% |
LoseRCKT / S&P RCKT unavailable / 5.38% |
LoseRCKT / S&P RCKT unavailable / 5.12% |
| 2024-Q10/3 |
LoseRCKT / S&P -10.11% / 10.56% |
LoseRCKT / S&P RCKT unavailable / 5.71% |
LoseRCKT / S&P RCKT unavailable / 5.59% |
| 2023-Q41/3 |
WinRCKT / S&P 46.27% / 11.69% |
LoseRCKT / S&P RCKT unavailable / 6.81% |
LoseRCKT / S&P RCKT unavailable / 7.78% |
| 2023-Q31/3 |
WinRCKT / S&P 3.12% / -3.27% |
LoseRCKT / S&P RCKT unavailable / 7.52% |
LoseRCKT / S&P RCKT unavailable / -5.03% |
| 2023-Q21/3 |
WinRCKT / S&P 16.00% / 8.74% |
LoseRCKT / S&P RCKT unavailable / 9.50% |
LoseRCKT / S&P RCKT unavailable / -8.57% |
| 2023-Q10/3 |
LoseRCKT / S&P -12.47% / 7.50% |
LoseRCKT / S&P RCKT unavailable / 10.77% |
LoseRCKT / S&P RCKT unavailable / -15.69% |
| 2022-Q41/3 |
WinRCKT / S&P 22.62% / 7.56% |
LoseRCKT / S&P RCKT unavailable / 11.88% |
LoseRCKT / S&P RCKT unavailable / -17.99% |
| 2022-Q31/3 |
WinRCKT / S&P 15.99% / -4.88% |
LoseRCKT / S&P RCKT unavailable / 13.47% |
LoseRCKT / S&P RCKT unavailable / -1.41% |
| 2022-Q21/3 |
WinRCKT / S&P -13.24% / -16.10% |
LoseRCKT / S&P RCKT unavailable / 13.71% |
LoseRCKT / S&P RCKT unavailable / 11.04% |
| 2022-Q10/3 |
LoseRCKT / S&P -27.35% / -4.60% |
LoseRCKT / S&P RCKT unavailable / 15.97% |
LoseRCKT / S&P RCKT unavailable / 42.23% |
| 2021-Q40/3 |
LoseRCKT / S&P -26.97% / 11.03% |
LoseRCKT / S&P RCKT unavailable / 15.00% |
LoseRCKT / S&P RCKT unavailable / 96.40% |
| 2021-Q30/3 |
LoseRCKT / S&P -32.51% / 0.58% |
LoseRCKT / S&P RCKT unavailable / 10.77% |
LoseRCKT / S&P RCKT unavailable / 69.42% |
| 2021-Q20/3 |
LoseRCKT / S&P -0.18% / 8.55% |
LoseRCKT / S&P RCKT unavailable / 6.58% |
LoseRCKT / S&P RCKT unavailable / 51.81% |
| 2021-Q10/3 |
LoseRCKT / S&P -19.09% / 6.17% |
LoseRCKT / S&P RCKT unavailable / -1.06% |
LoseRCKT / S&P RCKT unavailable / 7.39% |
| 2020-Q41/3 |
WinRCKT / S&P 139.90% / 12.15% |
LoseRCKT / S&P RCKT unavailable / -3.72% |
LoseRCKT / S&P RCKT unavailable / -33.42% |
| 2020-Q31/3 |
WinRCKT / S&P 9.22% / 8.93% |
LoseRCKT / S&P RCKT unavailable / -2.04% |
LoseRCKT / S&P RCKT unavailable / -27.10% |
| 2020-Q21/3 |
WinRCKT / S&P 50.04% / 20.54% |
LoseRCKT / S&P RCKT unavailable / -0.46% |
LoseRCKT / S&P RCKT unavailable / -27.11% |
| 2020-Q10/3 |
LoseRCKT / S&P -38.71% / -19.60% |
LoseRCKT / S&P RCKT unavailable / 3.47% |
LoseRCKT / S&P RCKT unavailable / -14.75% |
| 2019-Q41/3 |
WinRCKT / S&P 95.36% / 9.07% |
LoseRCKT / S&P RCKT unavailable / 5.36% |
LoseRCKT / S&P RCKT unavailable / 2.99% |
| 2019-Q30/3 |
LoseRCKT / S&P -22.33% / 1.70% |
LoseRCKT / S&P RCKT unavailable / 5.02% |
LoseRCKT / S&P RCKT unavailable / 0.21% |
| 2019-Q20/3 |
LoseRCKT / S&P -14.48% / 4.30% |
LoseRCKT / S&P RCKT unavailable / 6.64% |
LoseRCKT / S&P RCKT unavailable / 8.65% |
| 2019-Q11/3 |
WinRCKT / S&P 18.35% / 13.65% |
LoseRCKT / S&P RCKT unavailable / 8.12% |
LoseRCKT / S&P RCKT unavailable / 14.29% |
| 2018-Q40/3 |
LoseRCKT / S&P -39.81% / -13.52% |
LoseRCKT / S&P RCKT unavailable / 9.05% |
LoseRCKT / S&P RCKT unavailable / 18.23% |
| 2018-Q31/3 |
WinRCKT / S&P 25.42% / 7.71% |
LoseRCKT / S&P RCKT unavailable / 10.21% |
LoseRCKT / S&P RCKT unavailable / 19.06% |
| 2018-Q21/3 |
WinRCKT / S&P 4.69% / 3.43% |
LoseRCKT / S&P RCKT unavailable / 9.03% |
LoseRCKT / S&P RCKT unavailable / 14.46% |
| 2018-Q11/3 |
WinRCKT / S&P 79.60% / -0.76% |
LoseRCKT / S&P RCKT unavailable / 7.68% |
LoseRCKT / S&P RCKT unavailable / 12.46% |
| 2017-Q41/3 |
WinRCKT / S&P 46.63% / 6.64% |
LoseRCKT / S&P RCKT unavailable / 7.03% |
LoseRCKT / S&P RCKT unavailable / 13.82% |
| 2017-Q30/3 |
LoseRCKT / S&P -6.32% / 4.48% |
LoseRCKT / S&P RCKT unavailable / 5.68% |
LoseRCKT / S&P RCKT unavailable / 17.57% |
| 2017-Q20/3 |
LoseRCKT / S&P -5.00% / 3.09% |
LoseRCKT / S&P RCKT unavailable / 4.83% |
LoseRCKT / S&P RCKT unavailable / 17.74% |
| 2017-Q10/3 |
LoseRCKT / S&P -67.21% / 6.07% |
LoseRCKT / S&P RCKT unavailable / 3.67% |
LoseRCKT / S&P RCKT unavailable / 13.32% |
| 2016-Q40/3 |
LoseRCKT / S&P -35.65% / 3.82% |
LoseRCKT / S&P RCKT unavailable / 2.09% |
LoseRCKT / S&P RCKT unavailable / 7.05% |
| 2016-Q31/3 |
WinRCKT / S&P 27.42% / 3.85% |
LoseRCKT / S&P RCKT unavailable / 0.20% |
LoseRCKT / S&P RCKT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | RCKT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 17.68% | 20.78% |
| Annualized return | 17.68% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | RCKT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.45% | 83.14% |
| Annualized return | -36.22% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | RCKT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -86.54% | 319.30% |
| Annualized return | -18.17% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |